What Types of Cancer Are Targeted by CSF1R Inhibitors?
CSF1R inhibitors have shown potential in various types of cancer, including breast cancer, glioblastoma, and pancreatic cancer. These cancers often have a high density of TAMs, making them suitable targets for CSF1R inhibition. Preclinical and clinical studies are ongoing to determine the effectiveness of these inhibitors in different cancer types and stages.